Door still open for agreed takeover of Fisons

Drugs: Hopes fade for white knight in pounds 1.7bn bid as analysts pred ict return of merger mania

MATHEW HORSMAN

Hopes that a white knight might emerge to save Fisons from a hostile pounds 1.7bn bid launched by Rhone-Poulenc Rorer faded yesterday, as at least one competitor, Astra, ruled itself out and Fisons' shares fell 51/2p to end the day at 259p. But RPR senior management left the door open for an agreed offer, lauding the target company's chief executive and suggesting talks could resume.

Commenting on RPR's offer document, published yesterday, Robert Cawthorn, RPR's chairman, reiterated that the 240p a share offer fully valued Fisons, based on publicly available information. He said that Stuart Wallis, Fisons' chief executive, had done an excellent job restructuring his company and he remained "surprised and disappointed" that talks on an agreed deal had failed.

"In these situations, hostile bids can often become agreed bids," Mr Cawthorn said, hinting he would be prepared to meet Mr Wallis again. Fisons, which now has two weeks to publish its defence, had no comment.

Meanwhile, shares in the pharmaceuticals sector on both sides of the Atlantic rose yesterday, as analysts predicted the $200bn-a-year pharmaceuticals industry will again be gripped by merger mania.

Companies big, medium-sized and small are all struggling with the need to contain costs and expand market share. Analysts expect that the top 10 companies, which now control 37 per cent of the market, might take as much as a 50 per cent by the end of the decade.

Nigel Barnes, analyst with Merrill Lynch, says the action will be driven by the need for new products. "In the next five years, there will be a difference between those companies with a range of products and those without. The market is likely to prefer companies with a strong new product flow."

The pharmaceuticals team at NatWest Securities, meanwhile, say cost-cutting will be an equally important influence on company strategy. They expect sales forces to be further pruned, either by companies acting on their own or through mergers like that between Upjohn and Pharmacia, worth $13bn, which is expected to lead to savings of $500m.

"There is still fat in the industry, and consolidation will help you cut some of that," said RPR's Mr Cawthorn. But he stressed that "innovation is the driving force. Eventually the cost squeeze won't be able to cut costs further."

Innovation was the stated reason for Glaxo's pounds 9bn purchase of Wellcome earlier this year. Armed with a portfolio of products soon to be beyond their patent protection, and dependent on just four drugs for 80 per cent of profits, Glaxo was desperate for new products.

But most companies are far more diversified, with a range of drugs in various therapeutic fields. RPR, for example, derived 80 per cent of its profits from 80 different products last year. The company has set out to focus in four or five niche areas, leading with asthma medicine. Fisons' expertise in this field is its main attraction.

Given the varying reasons why companies either merge or seek strategic partners, picking likely winners in the pharmaceutical business is tricky. Likely success stories in the 1990s include Britain's Zeneca, widely tipped as a potential acquisition, and Merck, the US giant.

Analyst agree research and development is key, and companies that spend significantly on developing new products - particularly those associated with gene therapy - will be best placed. They also like firms with good geographic spread, particularly a strong presence in the US market, responsible for 40 per cent of all drug sales.

Pharmacia's merger with Upjohn, unveiled at the weekend, meets the diversification test: the Swedish concern gets a US presence, while Upjohn gains access to Pharmacia's impressive new product list. But is the merger mania a sign the industry is about to return to the heady days of the 1980s? Analysts are split: NatWest calls for a return to annual sales growth rates of 10 per cent by 2000, but others are more cautious.

The industry's fortunes are intimately tied to the political climate. Spiralling health care costs, along with a restructuring of the health care sector in North America and in Europe, saw the growth in spending on drugs tempered sharply in the early 1990s.

But cost consciousness may end up helping the pharmaceuticals business, analysts predict. An ageing population, coupled with pressures to introduce more preventive care in place of expensive hospitalisation, may give the drugs sector pride of place in health care.

Comment, page 17

Pharmaceuticals industry: the global deals

July 93 Merck buys Medco pounds 3.8bn

May 94 Roche buys Syntex pounds 3.4bn

May 94 Sandoz buys Gerber pounds 2.4bn

May 94 SKB buys Diversified Pharmaceuticals pounds 1.4bn

May 94 Hoechst buys Marion Merrell Dow pounds 4.6bn

July 94 Eli Lilly buys PCS pounds 2.6bn

Aug 94 American Home Products buys Cyanamid pounds 6.3bn

Aug 94 SKB buys Sterling Winthrop pounds 1.9bn

Mar 95 Glaxo buys Wellcome pounds 9.0bn

Aug 95 Rhone-Poulenc Rorer hostile offer Fisons pounds 1.7bn

Aug 95 Pharmacia agreed merger Upjohn pounds 8.4bn

News
people
Arts and Entertainment
Joel Edgerton, John Turturro and Christian Bale in Exodus: Gods and Kings
filmDirector said film would 'never have been financed' with ethnic minority actors in key roles
News
people
Sport
footballArsenal 2 Borussia Dortmund 0: And they can still top the group
PROMOTED VIDEO
Arts and Entertainment
An unseen image of Kurt Cobain at home featured in the film 'Kurt Cobain: Montage of Heck'
film
News
Andy Murray with his girlfriend of nine years, Kim Sears who he has got engaged to
peopleWimbledon champion announces engagement to girlfriend Kim Sears
Arts and Entertainment
Jake Quickenden and Edwina Currie are joining the I'm A Celebrity...Get Me Out Of Here! camp
tv
Arts and Entertainment
George Mpanga has been shortlisted for the Critics’ Choice prize
music
News
Albert Camus (left) and Jean-Paul Sartre fell out in 1952 and did not speak again before Camus’s death
people
Arts and Entertainment
Roisin, James and Sanjay in the boardroom
tvReview: This week's failing project manager had to go
News
ebooksNow available in paperback
News
Ed Miliband visiting the Holocaust museum in Jerusalem. The Labour leader has spoken more openly of his heritage recently
newsAttacks on the Labour leader have coalesced around a sense that he is different, weird, a man apart. But are the barbs more sinister?
Arts and Entertainment
'Felfie' (2014) by Alison Jackson
photographyNew exhibition shows how female creatives are changing the way women are portrayed in advertising
News
i100
Life and Style
Fright night: the board game dates back to at least 1890
life
Environment
The vaquita is being killed by fishermen trying to catch the totoaba fish, which is prized in China
environmentJust 97 of the 'world's cutest' sea mammals remain
Latest stories from i100
Have you tried new the Independent Digital Edition apps?
Independent Dating
and  

By clicking 'Search' you
are agreeing to our
Terms of Use.

iJobs Job Widget
iJobs Money & Business

SThree: Trainee Recruitment Consultants

£20000 - £25000 per annum + OTE £Competitive: SThree: SThree Group and have be...

Langley James : IT Support; Helpdesk, VMware; Manchester, £18k

£16000 - £18000 per annum: Langley James : IT Support; Helpdesk, VMware; Manch...

h2 Recruit Ltd: Business Development Manager - HRO - £70k+ ote

£35000 - £450000 per annum + £3k car, £70k ote: h2 Recruit Ltd: Do you want to...

Citifocus Ltd: Newly Qualified Accountants - Risk Mgmt

£Attractive Package: Citifocus Ltd: Prestigious financial institution seeks to...

Day In a Page

Cameron, Miliband and Clegg join forces for Homeless Veterans campaign

Cameron, Miliband and Clegg join forces for Homeless Veterans campaign

It's in all our interests to look after servicemen and women who fall on hard times, say party leaders
Millionaire Sol Campbell wades into wealthy backlash against Labour's mansion tax

Sol Campbell cries foul at Labour's mansion tax

The former England defender joins Myleene Klass, Griff Rhys Jones and Melvyn Bragg in criticising proposals
Nicolas Sarkozy returns: The ex-President is preparing to fight for the leadership of France's main opposition party – but will he win big enough?

Sarkozy returns

The ex-President is preparing to fight for the leadership of France's main opposition party – but will he win big enough?
Is the criticism of Ed Miliband a coded form of anti-Semitism?

Is the criticism of Miliband anti-Semitic?

Attacks on the Labour leader have coalesced around a sense that he is different, weird, a man apart. But is the criticism more sinister?
Ouija boards are the must-have gift this Christmas, fuelled by a schlock horror film

Ouija boards are the must-have festive gift

Simon Usborne explores the appeal - and mysteries - of a century-old parlour game
There's a Good Girl exhibition: How female creatives are changing the way women are portrayed in advertising

In pictures: There's a Good Girl exhibition

The new exhibition reveals how female creatives are changing the way women are portrayed in advertising
UK firm Biscuiteers is giving cookies a makeover - from advent calendars to doll's houses

UK firm Biscuiteers is giving cookies a makeover

It worked with cupcakes, doughnuts and macarons so no wonder someone decided to revamp the humble biscuit
Can SkySaga capture the Minecraft magic?

Can SkySaga capture the Minecraft magic?

It's no surprise that the building game born in Sweden in 2009 and now played by millions, has imitators keen to construct their own mega money-spinner
The King's School is way ahead of the pack when it comes to using the latest classroom technology

Staying connected: The King's School

The school in Cambridgeshire is ahead of the pack when it comes to using the latest classroom technology. Richard Garner discovers how teachers and pupils stay connected
Christmas 2014: 23 best women's perfumes

Festively fragrant: the best women's perfumes

Give a loved one a luxe fragrance this year or treat yourself to a sensual pick-me-up
Arsenal vs Borussia Dortmund: Alex Oxlade-Chamberlain celebrates century with trademark display of speed and intuition

Arsenal vs Borussia Dortmund

The Ox celebrates century with trademark display of speed and intuition
Billy Joe Saunders vs Chris Eubank Jnr: When two worlds collide

When two worlds collide

Traveller Billy Joe Saunders did not have a pampered public-school upbringing - unlike Saturday’s opponent Chris Eubank Jnr
Homeless Veterans Christmas Appeal: Drifting and forgotten - turning lives around for ex-soldiers

Homeless Veterans Christmas Appeal: Turning lives around for ex-soldiers

Our partner charities help veterans on the brink – and get them back on their feet
Putin’s far-right ambition: Think-tank reveals how Russian President is wooing – and funding – populist parties across Europe to gain influence in the EU

Putin’s far-right ambition

Think-tank reveals how Russian President is wooing – and funding – populist parties across Europe to gain influence in the EU
Tove Jansson's Moominland: What was the inspiration for Finland's most famous family?

Escape to Moominland

What was the inspiration for Finland's most famous family?